{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:47:59Z","timestamp":1791406079262,"version":"4.3.3"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Syndrome of inappropriate antidiuresis (SIAD) is a common cause of hyponatraemia, with fluid restriction (FR) failing in nearly half of patients. Although furosemide combined with oral sodium chloride (NaCl) tablets is widely used as second-line therapy, evidence supporting its effectiveness after FR failure remains limited, and predictors of response have not been established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective multicentre cohort study enrolled hospitalized adults with SIAD who failed FR at two tertiary centres in Thailand between October 2022 and September 2025. Patients received oral NaCl tablets (3.6\u00a0g daily) and furosemide (40\u00a0mg daily) while continuing FR. The primary outcome was the daily rate of serum sodium correction. Predictors of response were identified using multivariable linear mixed-effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 88 patients (68% male; median age 65 years), the median baseline serum sodium was 124\u00a0mmol\/l. Serum sodium increased by 1.51\u00a0mmol\/l per day [95% confidence interval (CI) 1.37\u20131.66], reaching a median of 130\u00a0mmol\/l by day 4 and 134\u00a0mmol\/l by day 7. Three factors independently predicted faster correction: higher body weight (\u03b2 0.85\u00a0mmol\/l per 10\u00a0kg; 95% CI 0.28\u20131.42), lower baseline sodium (\u03b2 \u22120.58 per 1\u00a0mmol\/l lower; 95% CI\u00a0\u22120.77 to\u00a0\u22120.39), and drug-induced aetiology (\u03b2 7.17\u00a0mmol\/l; 95% CI 3.48\u201310.85). Adverse events included hypokalaemia (51%), hypomagnesaemia (29.5%), and acute kidney injury (18.2%). Overcorrection occurred in one (1.1%) patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Furosemide combined with oral NaCl tablets is a practical second-line option for SIAD after FR failure, achieving sodium correction of 1.5\u00a0mmol\/l per day. Higher body weight, lower baseline sodium, and drug-induced aetiology predict faster correction. Randomized controlled trials are needed to confirm efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag107","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:51:29Z","timestamp":1775130689000},"source":"Crossref","is-referenced-by-count":2,"title":["Furosemide plus oral sodium chloride for syndrome of inappropriate antidiuresis after fluid restriction failure"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6382-2656","authenticated-orcid":false,"given":"Kittiphan","family":"Chienwichai","sequence":"first","affiliation":[{"name":"Hatyai Hospital Division of Nephrology, Department of Internal Medicine, , Songkhla ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitsinee","family":"Laipanngam","sequence":"additional","affiliation":[{"name":"Hatyai Hospital Department of Internal Medicine, , Songkhla ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirin","family":"Jiwakanon","sequence":"additional","affiliation":[{"name":"Hatyai Hospital Division of Nephrology, Department of Internal Medicine, , Songkhla ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamonrat","family":"Chaiviriyawong","sequence":"additional","affiliation":[{"name":"Hatyai Hospital Division of Nephrology, Department of Internal Medicine, , Songkhla ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jananya","family":"Wattanakul","sequence":"additional","affiliation":[{"name":"Hatyai Hospital Division of Nephrology, Department of Internal Medicine, , Songkhla ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunchai","family":"Chang","sequence":"additional","affiliation":[{"name":"Hatyai Hospital Division of Gastroenterology, Department of Internal Medicine, , Songkhla ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pannawat","family":"Mongkolrattanakul","sequence":"additional","affiliation":[{"name":"Phanatnikhom Hospital Division of Nephrology, Department of Internal Medicine, , Chonburi ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"2026050104461302000_bib1","doi-asserted-by":"publisher","first-page":"e240666","DOI":"10.1530\/EC-24-0666","article-title":"Characteristics, management and outcomes of patients with hyponatraemia presenting to an Irish tertiary hospital","volume":"14","author":"Courtney","year":"2025","journal-title":"Endocr Connect"},{"key":"2026050104461302000_bib2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cccn.2003.08.001","article-title":"Age and gender as risk factors for hyponatremia and hypernatremia","volume":"337","author":"Hawkins","year":"2003","journal-title":"ClinChimActa"},{"key":"2026050104461302000_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3389\/fmed.2020.00512","article-title":"Prevalence and description of hyponatremia in a Swiss tertiary care hospital: an observational retrospective study","volume":"7","author":"Lu","year":"2020","journal-title":"Front Med"},{"key":"2026050104461302000_bib4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1001\/archinternmed.2009.513","article-title":"Impact of hospital-associated hyponatremia on selected outcomes","volume":"170","author":"Wald","year":"2010","journal-title":"Arch Intern Med"},{"key":"2026050104461302000_bib5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2265.2006.02583.x","article-title":"Characteristics and mortality of severe hyponatraemia\u2014a hospital-based study","volume":"65","author":"Gill","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026050104461302000_bib6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5144\/0256-4947.2024.339","article-title":"Prevalence of hyponatremia among medically hospitalized patients and associated outcomes: a retrospective cohort study","volume":"44","author":"Yaqoubi","year":"2024","journal-title":"Ann Saudi Med"},{"key":"2026050104461302000_bib7","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1185\/03007990802081675","article-title":"Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients","volume":"24","author":"Zilberberg","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"2026050104461302000_bib8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12882-017-0744-x","article-title":"The prevalence and mortality of hyponatremia is seriously underestimated in Chinese general medical patients: an observational retrospective study","volume":"18","author":"Hao","year":"2017","journal-title":"BMC Nephrol"},{"key":"2026050104461302000_bib9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1445-5994.2010.02217.x","article-title":"Severe hyponatraemia in elderly hospitalized patients: prevalence, aetiology and outcome","volume":"40","author":"Shapiro","year":"2010","journal-title":"Intern Med J"},{"key":"2026050104461302000_bib10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.amjmed.2010.01.013","article-title":"Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study","volume":"123","author":"Fenske","year":"2010","journal-title":"Am J Med"},{"key":"2026050104461302000_bib11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1210\/endrev\/bnad010","article-title":"Syndrome of inappropriate antidiuresis: from pathophysiology to management","volume":"44","author":"Warren","year":"2023","journal-title":"Endocr Rev"},{"key":"2026050104461302000_bib12","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"170","author":"Spasovski","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2026050104461302000_bib13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"key":"2026050104461302000_bib14","doi-asserted-by":"publisher","first-page":"e4360","DOI":"10.1210\/clinem\/dgaa619","article-title":"Fluid restriction therapy for chronic SIAD: results of a prospective randomized controlled trial","volume":"105","author":"Garrahy","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026050104461302000_bib15","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMcp2210411","article-title":"The syndrome of inappropriate antidiuresis","volume":"389","author":"Adrogu\u00e9","year":"2023","journal-title":"N Engl J Med"},{"key":"2026050104461302000_bib16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/bmj.285.6335.89","article-title":"Inappropriate secretion of antidiuretic hormone treated with frusemide","volume":"285","author":"Decaux","year":"1982","journal-title":"BMJ"},{"key":"2026050104461302000_bib17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/j.ajkd.2019.11.012","article-title":"Efficacy of furosemide, oral sodium chloride, and fluid restriction for treatment of syndrome of inappropriate antidiuresis (SIAD): an open-label randomized controlled study (The EFFUSE-FLUID Trial)","volume":"76","author":"Krisanapan","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2026050104461302000_bib18","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.34067\/KID.0000000912","article-title":"Urine electrolyte to predict treatment failure of fluid restriction in syndrome of inappropriate antidiuresis: a prospective multicenter study","volume":"6","author":"Chienwichai","year":"2025","journal-title":"Kidney360"},{"key":"2026050104461302000_bib19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/ndt\/gfae164","article-title":"Clinical factors associated with hyponatremia correction during treatment with oral urea","volume":"40","author":"Pelouto","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026050104461302000_bib20","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"2026050104461302000_bib21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/0002-9343(67)90096-4","article-title":"The syndrome of inappropriate secretion of antidiuretic hormone","volume":"42","author":"Bartter","year":"1967","journal-title":"Am J Med"},{"key":"2026050104461302000_bib22","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"2026050104461302000_bib23","volume-title":"A Language and Environment for Statistical Computing. R Foundation for Statistical Computing","author":"R Core Team","year":"2024"},{"key":"2026050104461302000_bib24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Soft"},{"key":"2026050104461302000_bib25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/joim.12532","article-title":"Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis","volume":"280","author":"Winzeler","year":"2016","journal-title":"J Intern Med"},{"key":"2026050104461302000_bib26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1681\/ASN.2019090944","article-title":"A randomized trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis","volume":"31","author":"Refardt","year":"2020","journal-title":"JASN"},{"key":"2026050104461302000_bib27","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1053\/j.ajkd.2017.12.002","article-title":"Rapidity of correction of hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone following tolvaptan","volume":"71","author":"Morris","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2026050104461302000_bib28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/ejendo\/lvad028","article-title":"Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia","volume":"188","author":"Pelouto","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2026050104461302000_bib29","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.2215\/CJN.00910207","article-title":"Hypertonic saline for hyponatremia: risk of inadvertent overcorrection","volume":"2","author":"Mohmand","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026050104461302000_bib30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/ejendo\/lvad028","article-title":"Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia","volume":"188","author":"Pelouto","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2026050104461302000_bib31","doi-asserted-by":"publisher","first-page":"110654","DOI":"10.1016\/j.jpsychores.2021.110654","article-title":"Management of SIADH-related hyponatremia due to psychotropic medications\u2014an expert consensus from the Association of Medicine and Psychiatry","volume":"151","author":"Pinkhasov","year":"2021","journal-title":"J Psychosom Res"},{"key":"2026050104461302000_bib32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/00185787211037548","article-title":"Safety and efficacy of urea for hyponatremia","volume":"57","author":"Hammonds","year":"2022","journal-title":"Hosp Pharm"},{"key":"2026050104461302000_bib33","doi-asserted-by":"publisher","first-page":"EVIDoa2200215","DOI":"10.1056\/EVIDoa2200215","article-title":"Osmotic demyelination syndrome in patients hospitalized with hyponatremia","volume":"2","author":"MacMillan","year":"2023","journal-title":"NEJM Evidence"},{"key":"2026050104461302000_bib34","first-page":"450","article-title":"Response of the kidney to furosemide: I. Effects of salt intake and renal compensation","volume":"102","author":"Wilcox","year":"1983","journal-title":"J Lab Clin Med"},{"key":"2026050104461302000_bib35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/jamainternmed.2024.5981","article-title":"Correction rates and clinical outcomes in hospitalized adults with severe hyponatremia: a systematic review and meta-analysis","volume":"185","author":"Ayus","year":"2025","journal-title":"JAMA Intern Med"},{"key":"2026050104461302000_bib36","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1210\/clinem\/dgaf538","article-title":"Tolvaptanvs fluid restriction in moderate-profound hyponatremia: an open-label randomized clinical trial","volume":"111","author":"Warren","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026050104461302000_bib37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1530\/EJE-10-1078","article-title":"Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion","volume":"164","author":"Verbalis","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2026050104461302000_bib38","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/cen.12943","article-title":"Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion","volume":"84","author":"Tzoulis","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026050104461302000_bib39","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.eprac.2025.04.012","article-title":"Low-dose tolvaptan for the treatment of syndrome of inappropriate antidiuretic hormone\u2013associated hyponatremia: a systematic review, meta-analysis, and meta-regression analysis of clinical effectiveness and safety","volume":"31","author":"Lewellyn","year":"2025","journal-title":"Endocr Pract"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag107\/67782807\/sfag107.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/5\/sfag107\/67782807\/sfag107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/5\/sfag107\/67782807\/sfag107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:46:18Z","timestamp":1777625178000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag107\/8586394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag107","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,3]]},"article-number":"sfag107"}}